June 6, 2011
Bharatbook.com introduce market report about The scope of this study encompasses the vaccine human and animal (veterinary) markets. BCC analyzes each market
Its applications by its need for disease type requiring vaccination, regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments.
* Global sales of human and animal vaccines reached approximately $25.2 billion in 2009. The market is expected to rise at a compound annual growth rate (CAGR) of 17.9% to reach $64.2 billion by 2015.
* The global market for human vaccines in 2008 was $18.7 billion and, with a continuing increase in the global market, reached $21.2 billion in 2009. This market is expected to rise at a compound annual growth rate (CAGR) of 19.6% to reach $58.6 billion by the end of 2015.
* The animal vaccines market grew from approximately $3.8 billion in 2008 to about $4.0 billion in 2009, an increase of about 5.9%. This market is expected to increase at a 5.7% compound annual growth rate (CAGR) between 2010 and 2015 to reach $5.6 billion in 2015.
BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for human and animal (veterinary) vaccines and related vaccine technologies. The key objective is to present a comprehensive analysis of the current market and its future direction in the human and animal (veterinary) vaccines market with their utilization and employment in preventing and/or treating infectious diseases.
This report explores present and future strategies within the human and animal (veterinary) vaccines market, including attenuated (live) vaccines, inactivated (killed) vaccines, conjugate vaccines, recombinant/recombinant DNA (rDNA) vaccines, subunit vaccines, toxoid vaccines, and combination vaccines. The current state of the market, the setbacks, the innovations, and the future needs of the market are discussed in this report. A general overview of vaccines, and related technologies used currently and in the past are discussed in the report.
A detailed analysis of the vaccine industry structure has been conducted. This includes all seven major categories of vaccines broken down by market share belonging to leading manufacturers and/or suppliers. Revenues for each of the seven categories of vaccines are broken down by region. Sales figures are estimated for the 5–year period from 2010 through 2015.
Applications for human and animal (veterinary) vaccines, as to their prophylactic or therapeutic use are also discussed separately in the report, with emphasis in the meningococcal/pneumococcal vaccines, influenza vaccines, pediatric vaccines, adult/adolescent vaccines, travel vaccines, and others. The report also includes significant patents and their allotments in each vaccine technology category.
REASONS FOR DOING THIS STUDY
This study was conducted to provide vital and detailed information regarding human and animal (veterinary) vaccines. The vaccines industry is experiencing growth due to new products hitting the market as well as a general increase in public awareness and more standardized immunization schedules. This study was conducted to provide detailed market analysis of human and animal (veterinary) vaccines along with the different factors affecting this market. While the vaccines market was affected by the global economic downturn, it retained steady growth and new developments are expected to further influence the market.
For more information kindly visit:
Supercapacitors : Technology Developments and Global Markets
Wire and Cable: Materials, Technologies and Global Markets
Contact Us at:
Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Follow us on twitter: http://twitter.com/#!/BharatBook
Please visit our blog at http://bharatresearch.wordpress.com